[ad_1]
Comply with us on 
Bharat Biotech will get approval for intranasal Covid-19 booster dose trials
The Medication Controller Normal of India (DCGI) has granted permission to Hyderabad-based biotechnology agency Bharat Biotech for intranasal booster dose trials, information company ANI reported. The trials will likely be achieved at 9 completely different websites.
READ MORE: Bharat Biotech’s nasal Covid booster dose will get DCGI approval for Part III trial
Newest India Information
[ad_2]
Source link
ADVERTISEMENT
